Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Climate change

Climate change reduces HIV treatment adherence in Africa

Editor's pick
Africa Health Research Institute
29 April 2022
Exposure to HIV through medical procedures

Canadian Blood Services to end 'blood ban,' bring in behaviour-based screening

Editor's pick
Vancouver Sun
29 April 2022

News from infohep, April 2022

April 2022
People with limited treatment options

Theratechnologies to Focus Its Commercialization Activities on the North American Territory

Editor's pick
Theratechnologies press release
28 April 2022
Menopause

Clinicians Aren’t Talking to Women With HIV About Menopause

Editor's pick
POZ
28 April 2022
Ageing & HIV

Polypharmacy Common Among Patients Aged 65 or Older With HIV

Editor's pick
Medscape (requires free registration)
28 April 2022

News from the British HIV Association conference – HIV update, 28 April 2022

April 2022
Access to healthcare

The COVID-19 pandemic disrupted HIV prevention and care in Barcelona, but new cases and viral loads didn’t increase

News
28 April 2022
Pharmaceutical industry

J&J sues to block sales of 'dangerous' counterfeit HIV drugs

Editor's pick
Reuters
27 April 2022
Changing treatment

‘The Devil You Know’: Many People Over 50 Are Taking Outdated ART, Despite Side Effects

Editor's pick
TheBodyPro
27 April 2022
Bad science & bogus treatments

WHO Warns of Dangers of Health Misinformation Across Social Media Following Elon Musk’s $44 bn Twitter Acquisition 

Editor's pick
Health Policy Watch
27 April 2022
People & personal stories

Transgender and Openly HIV-Positive 'Transparent' Star Alexandra Billings Discusses Her New Memoir

Editor's pick
TheBody
27 April 2022
Pharmaceutical industry

GSK's ViiV, Pfizer and Roche's Genentech earn top ranks among patient advocacy groups

Editor's pick
FiercePharma
27 April 2022
Epidemiology & behaviour

San Francisco supervisors lift gay bathhouse prohibitions

Editor's pick
Bay Area Reporter
27 April 2022
Retention & linkage to care

South London clinics find the people lost to HIV care – and tell some of their stories

News
27 April 2022
Access to healthcare

Tigray's health system 'totally collapsed', say health workers

Editor's pick
The New Humanitarian
26 April 2022
Pharmaceutical industry

Buckle up! The ‘Staley vs Gilead’ lawsuit could cost Big Pharma billions

Editor's pick
My Fabulous Disease
26 April 2022
Activism & civil society

Aid Workers in Ukraine Fight to Deliver Supplies Despite Lives Lost to Russian Shelling

Editor's pick
The New York Times
26 April 2022
Access to healthcare

PEPFAR Investing US $13 Million to Reach Ukrainians in Need with Life-Saving HIV Treatment

Editor's pick
U.S. Department of State
26 April 2022
Clinical trials

HIV Cure Research Lacks Diversity From the Earliest Stages, Scientists Warn

Editor's pick
TheBodyPro
26 April 2022
The biology of HIV transmission

HIV Transmitted Through Heterosexual Sex May Initially Be ‘Fitter,’ but Likely Has No Effect on Prevention and Treatment

Editor's pick
TheBodyPro
26 April 2022
Elimination of hepatitis C

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV

News
26 April 2022
Harm reduction

Sustaining HIV services for people who use drugs in Odesa

Editor's pick
UNAIDS
25 April 2022
Neurological & cognitive problems

Computerized Cognitive Training May Help HIV-Associated Neurocognitive Disorder

Editor's pick
Infectious Disease Advisor
25 April 2022